Glioprotective Effects of Ashwagandha Leaf Extract against Lead Induced Toxicity
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Withania somnifera(Ashwagandha), also known as Indian Ginseng, is a well-known Indian medicinal plant due to its antioxidative, antistress, antigenotoxic, and immunomodulatory properties. The present study was designed to assess and establish the cytoprotective potential of Ashwagandha leaf aqueous extract against lead induced toxicity. Pretreatment of C6 cells with 0.1% Ashwagandha extract showed cytoprotection against 25 μ M to 400 μ M concentration of lead nitrate. Further pretreatment with Ashwagandha extract to lead nitrate exposed cells (200 μ M) resulted in normalization of glial fibrillary acidic protein (GFAP) expression as well as heat shock protein (HSP70), mortalin, and neural cell adhesion molecule (NCAM) expression. Further, the cytoprotective efficacy of Ashwagandha extract was studied in vivo. Administration of Ashwagandha extract provided significant protection to lead induced altered antioxidant defense that may significantly compromise normal cellular function. Ashwagandha also provided a significant protection to lipid peroxidation (LPx) levels, catalase, and superoxide dismutase (SOD) but not reduced glutathione (GSH) contents in brain tissue as well as peripheral organs, liver and kidney, suggesting its ability to act as a free radical scavenger protecting cells against toxic insult. These results, thus, suggest that Ashwagandha water extract may have the potential therapeutic implication against lead poisoning.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative Stress in Neurodegenerative Diseases
Simonian, N. A., & Coyle, J. T. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.000503 · Cited by 1,377
Withania somnifera: an Indian ginseng
Kulkarni, S. K., & Dhir, A. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.09.011 · Cited by 416 · cited 2×
“It is considered to be Indian Ginseng due to its rejuvenating effects on the body such as antioxidative, antistress, antigenotoxic, and immunomodulatory properties [2, 3].”
BackgroundNeuritic regeneration and synaptic reconstruction induced by withanolide A
Kuboyama, T., Tohda, C., & Komatsu, K. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706122 · Cited by 339 · cited 1×
“Neuroregeneration of both axons and dendrites as well as reconstruction of pre- and postsynapses in the neurons was induced by withanolide A from the Ashwagandha extract which is considered to be an important candidate for the treatment of neurodegenerative diseases [50].”
BackgroundKonar, A., Shah, N., Singh, R., Saxena, N., Kaul, S. C., Wadhwa, R., & Thakur, M. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027265 · Cited by 193 · cited 1×
“Recently, it has been shown that Ashwagandha extract and its bioactive component Withanone was able to revert scopolamine induced changes in GFAP expression in the neuronal cells aswell as animalmodel [33].”
BackgroundSelf-citationNeuroprotective Effects of Withania somnifera Dunn. in Hippocampal Sub‐regions of Female Albino Rat
Jain, S., Shukla, S. D., Sharma, K., & Bhatnagar, M. (2001) · Phytotherapy Research · doi:10.1002/ptr.802 · Cited by 101 · cited 2×
“The bioactive components sitoindosides VII-X and withaferin A have been shown to have neuroprotective activity by binding with cholinergic receptors [48].”
BackgroundKataria, H., Wadhwa, R., Kaul, S. C., & Kaur, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037080 · Cited by 77 · cited 3×
“A recent study onAshwagandha treatment inC6 glioma cells has shown significant increase in expression of NCAM [39] and also increase in NCAM expression after Ashwagandha treatment has been associatedwith protection against glutamate induced damage in RA differentiated neuronal cultures [34].”
BackgroundTohda, C., & Joyashiki, E. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00313.x · Cited by 62
Kaur, M., Sharma, S., & Kaur, G. (2008) · Biogerontology · doi:10.1007/s10522-008-9168-0 · Cited by 42 · cited 1×
“which is involved in controlling movement and shape of astrocytes, differentiation marker of glial cells/and increased GFAP expression which has been associated with aging [11, 12].”
BackgroundSelf-citation
Cited by
Pharmacologic overview of Withania somnifera, the Indian Ginseng
Dar, N. J., Hamid, A., & Ahmad, M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2012-1 · Cited by 370
Paul, S., Chakraborty, S., Anand, U., Dey, S., Nandy, S., Ghorai, M., Saha, S. C., Patil, M. T., Kandimalla, R., Proćków, J., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112175 · Cited by 306
Neurodegenerative diseases and Withania somnifera (L.): An update
Dar, N. J., & Ahmad, M. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112769 · Cited by 123
Ahmed, W., Mofed, D., Zekri, A.-R., El-Sayed, N., Rahouma, M., & Sabet, S. (2018) · Journal of International Medical Research · doi:10.1177/0300060517752022 · Cited by 56
“The sterile filtrate was treated as 100% ASH-WX as previously described and stored at –20 C for future use.(26)”
MethodDutta, K., Patel, P., & Julien, J.-P. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.08.008 · Cited by 56
“Several studies based on the use of cultured cell lines reported that WS extract or withaferin A reduce Hsps70 and 90 activities (Kataria et al., 2012; Kumar et al., 2014; Yu et al., 2010) whereas others reported that they induce the activities of Hsps70, 32 and 27 (Grogan et al.”
Background
Metadata
- Authors
- Kumar, P., Singh, R., Nazmi, A., Lakhanpal, D., Kataria, H., & Kaur, G.
- Venue
- BioMed Research International
- Publisher
- Hindawi Limited
- Published
- 2014
- Volume
- 2014
- Pages
- 1-15
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W1999782817
- Cited by
- 53
- References
- 8
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.